Stockscreener 앱 받기
18.97
3.10%
0.57
시장 영업 전:
17.97
-1.00
-5.27%
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
AnaptysBio (NASDAQ:ANAB) Trading 2.5% HigherTime to Buy? - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Stock Holdings Increased by Swiss National Bank - Defense World
How to Take Advantage of moves in (ANAB) - news.stocktradersdaily.com
AnaptysBio (NASDAQ:ANAB) Shares Gap UpShould You Buy? - MarketBeat
Charles Schwab Investment Management Inc. Acquires 5,733 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio (NASDAQ:ANAB) Trading Down 4.1%Should You Sell? - MarketBeat
AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Stock - MarketBeat
Bank of New York Mellon Corp Sells 1,972 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
Leerink Partners Sticks to Their Buy Rating for AnaptysBio (ANAB) - The Globe and Mail
AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last? - MSN
AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Shares - Defense World
AnaptysBio Shares Jump on Buyback Program Authorization - MarketWatch
Crude Oil Gains 1%; US Composite PMI Surges In March - Benzinga
Anaptys Announces Stock Repurchase Plan - GlobeNewswire
AnaptysBio authorizes $75 million stock buyback plan By Investing.com - Investing.com South Africa
Anaptys announces $75 million stock repurchase plan - MSN
AnaptysBio Announces $75 Mln Stock Repurchase Plan - Nasdaq
AnaptysBio stock rises following stock repurchase plan By Investing.com - Investing.com Canada
Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday - Benzinga
AnaptysBio Approves $75 Million Buyback Plan; Shares Rise -March 24, 2025 at 09:50 am EDT - Marketscreener.com
AnaptysBio authorizes $75 million stock buyback plan - Investing.com India
AnaptysBio, Inc. Authorizes $75 Million Stock Repurchase Plan - Nasdaq
AnaptysBio (NASDAQ:ANAB) Trading Up 4.4%Still a Buy? - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
AlphaQuest LLC Purchases 4,237 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Position Raised by Victory Capital Management Inc. - MarketBeat
Victory Capital Management Inc. Purchases 97,200 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - markets.businessinsider.com
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $42.00 - MarketBeat
Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
HC Wainwright Reaffirms Neutral Rating for AnaptysBio (NASDAQ:ANAB) - MarketBeat
When (ANAB) Moves Investors should Listen - Stock Traders Daily
AnaptysBio (NASDAQ:ANAB) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - Defense World
23,497 Shares in AnaptysBio, Inc. (NASDAQ:ANAB) Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Leerink Partnrs Weighs in on AnaptysBio FY2029 Earnings - MarketBeat
AnaptysBio (ANAB) to Release Quarterly Earnings on Monday - MarketBeat
AnaptysBio: A Shadow Of Its Former Self (NASDAQ:ANAB) - Seeking Alpha
Palmoplantar Pustulosis Clinical and Non-Clinical Studies, - openPR
AnaptysBio’s (ANAB) Neutral Rating Reaffirmed at HC Wainwright - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Update - MarketBeat
2.00%
자본화:
|
볼륨(24시간):